Other inhibitory checkpoint pathways such as PD-1, TIM-3, LAG-3, and TIGIT likely contribute to T cell regulation after stroke but were beyond the scope of this focused analysis and should be addressed in future studies. This evidence concerns the gene HAVCR2 and stroke disorder.